(Q42455548)

English

Metformin administration was associated with a modification of LH, prolactin and insulin secretion dynamics in women with polycystic ovarian syndrome

scientific article published on July 2009

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

31 October 2017

Metformin administration was associated with a modification of LH, prolactin and insulin secretion dynamics in women with polycystic ovarian syndrome (English)

1 reference

Europe PubMed Central

31 October 2017

1 reference

based on heuristic

inferred from title

author name string

Evangelia Billa

1

1 reference

Europe PubMed Central

31 October 2017

Niki Kapolla

2

1 reference

Europe PubMed Central

31 October 2017

Stamatina C Nicopoulou

3

1 reference

Europe PubMed Central

31 October 2017

Eftychia Koukkou

4

1 reference

Europe PubMed Central

31 October 2017

Evangelia Venaki

5

1 reference

Europe PubMed Central

31 October 2017

Spyros Milingos

6

1 reference

Europe PubMed Central

31 October 2017

Aristides Antsaklis

7

1 reference

Europe PubMed Central

31 October 2017

Dimitrios A Adamopoulos

8

1 reference

Europe PubMed Central

31 October 2017

publication date

1 July 2009

1 reference

Europe PubMed Central

31 October 2017

Gynecological Endocrinology

1 reference

Europe PubMed Central

31 October 2017

25

1 reference

Europe PubMed Central

31 October 2017

7

1 reference

Europe PubMed Central

31 October 2017

427-434

1 reference

Europe PubMed Central

31 October 2017

Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Metformin-induced resumption of normal menses in 39 of 43 (91%) previously amenorrheic women with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Clomiphene, Metformin, or Both for Infertility in the Polycystic Ovary Syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Metformin for the treatment of polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Descriptive review of the evidence for the use of metformin in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Insulin-sensitizing agents in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Effects of metformin on inappropriate LH release in women with polycystic ovarian syndrome and insulin resistance

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Metformin administration modulates and restores luteinizing hormone spontaneous episodic secretion and ovarian function in nonobese patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Metformin administration modulates neurosteroids secretion in non-obese amenorrhoic patients with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Clinical assessment of body hair growth in women

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

A mathematical model for the determination of total area under glucose tolerance and other metabolic curves

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Quantitative insulin sensitivity check index: a simple, accurate method for assessing insulin sensitivity in humans.

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Evidence for altered catecholamine metabolism in polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Hypothalamic dopaminergic tone and prolactin bioactivity in women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Thyrotropin Suppression by Metformin

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Metformin administration is more effective when non-obese patients with polycystic ovary syndrome show both hyperandrogenism and hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1080%2F09513590902770172

21 January 2018

Identifiers

10.1080/09513590902770172

1 reference

Europe PubMed Central

31 October 2017

1 reference

Europe PubMed Central

31 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q42455548&oldid=1958090909"